Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Leukotriene receptor blockade as a life-saving treatment in severe bronchopulmonary dysplasia.

Rupprecht T, Rupprecht C, Harms D, Sterlacci W, Vieth M, Seybold K.

Respiration. 2014;88(4):285-90. doi: 10.1159/000365488. Epub 2014 Aug 30. Erratum in: Respiration. 2014;88(5):370.

2.

Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.

Dantonello TM, Int-Veen C, Harms D, Leuschner I, Schmidt BF, Herbst M, Juergens H, Scheel-Walter HG, Bielack SS, Klingebiel T, Dickerhoff R, Kirsch S, Brecht I, Schmelzle R, Greulich M, Gadner H, Greiner J, Marky I, Treuner J, Koscielniak E.

J Clin Oncol. 2009 Mar 20;27(9):1446-55. doi: 10.1200/JCO.2007.15.0466. Epub 2009 Feb 17.

PMID:
19224858
3.

Germ cell tumors of the head and neck: report from the MAKEI Study Group.

Bernbeck B, Schneider DT, Bernbeck B, Koch S, Teske C, Lentrodt J, Harms D, Göbel U, Calaminus G; MAKEI-Study Group.

Pediatr Blood Cancer. 2009 Feb;52(2):223-6. doi: 10.1002/pbc.21752.

PMID:
18937314
4.

Nonviable tumor tissue should not upstage Wilms' tumor from stage I to stage II: a report from the SIOP 93-01 nephroblastoma trial and study.

Vujanić GM, Harms D, Bohoslavsky R, Leuschner I, de Kraker J, Sandstedt B.

Pediatr Dev Pathol. 2009 Mar-Apr;12(2):111-5. doi: 10.2350/08-03-0432.1. Epub 2008 Sep 23.

PMID:
18811224
5.

KIT, PDGFRalpha and EGFR analysis in nephroblastoma.

Wetli SC, Leuschner I, Harms D, Rufle A, Foerster A, Bihl M, Graf N, Furtwaengler R, Paulussen M, Briner J, Aslanidis C, Schmitz G, Tornillo L, Mihatsch MJ, Zlobec I, Bruder E.

Virchows Arch. 2008 Jun;452(6):637-50. doi: 10.1007/s00428-008-0605-x. Epub 2008 May 14.

PMID:
18478259
6.

Wnt signaling pathway analysis in renal cell carcinoma in young patients.

Bruder E, Moch H, Ehrlich D, Leuschner I, Harms D, Argani P, Briner J, Graf N, Selle B, Rufle A, Paulussen M, Koesters R.

Mod Pathol. 2007 Dec;20(12):1217-29. Epub 2007 Sep 14.

7.

Clonality in juvenile xanthogranuloma.

Janssen D, Fölster-Holst R, Harms D, Klapper W.

Am J Surg Pathol. 2007 May;31(5):812-3. No abstract available.

PMID:
17460468
8.

Ovarian small cell carcinoma of the hypercalcemic type in children and adolescents: a prognostically unfavorable but curable disease.

Distelmaier F, Calaminus G, Harms D, Sträter R, Kordes U, Fleischhack G, Göbel U, Schneider DT.

Cancer. 2006 Nov 1;107(9):2298-306.

9.

Imbalances of chromosome arm 1p in pediatric and adult germ cell tumors are caused by true allelic loss: a combined comparative genomic hybridization and microsatellite analysis.

Zahn S, Sievers S, Alemazkour K, Orb S, Harms D, Schulz WA, Calaminus G, Göbel U, Schneider DT.

Genes Chromosomes Cancer. 2006 Nov;45(11):995-1006.

PMID:
16897744
10.

Genetic clonality is a feature unifying nephroblastomas regardless of the variety of morphological subtypes.

Guertl B, Leuschner I, Harms D, Hoefler G.

Virchows Arch. 2006 Aug;449(2):171-4. Epub 2006 May 20.

PMID:
16715229
11.

Treatment of severe disseminated juvenile systemic xanthogranuloma with multiple lesions in the central nervous system.

Dölken R, Weigel S, Schröder H, Hartwig M, Harms D, Beck JF.

J Pediatr Hematol Oncol. 2006 Feb;28(2):95-7.

PMID:
16462582
12.

Ovarian sex cord-stromal tumors in children and adolescents.

Schneider DT, Calaminus G, Harms D, Göbel U; German Maligne Keimzelltumoren Study Group.

J Reprod Med. 2005 Jun;50(6):439-46. Review.

PMID:
16050568
13.

Abdominal inflammatory masses mimicking neoplasia in children-experience of two centers.

Czauderna P, Schaarschmidt K, Komasara L, Harms D, Lempe M, Vorpahl K, Szumera M, Balanda A.

Pediatr Surg Int. 2005 May;21(5):346-50. Epub 2005 Apr 7.

PMID:
15815933
14.

Low occurrence of familial neuroblastomas and ganglioneuromas in five consecutive GPOH neuroblastoma treatment studies.

Claviez A, Lakomek M, Ritter J, Suttorp M, Kremens B, Dickerhoff R, Harms D, Berthold F, Hero B.

Eur J Cancer. 2004 Dec;40(18):2760-5.

PMID:
15648116
16.

Morphologic and molecular characterization of renal cell carcinoma in children and young adults.

Bruder E, Passera O, Harms D, Leuschner I, Ladanyi M, Argani P, Eble JN, Struckmann K, Schraml P, Moch H.

Am J Surg Pathol. 2004 Sep;28(9):1117-32.

PMID:
15316311
17.

Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols.

Schneider DT, Calaminus G, Koch S, Teske C, Schmidt P, Haas RJ, Harms D, Göbel U.

Pediatr Blood Cancer. 2004 Feb;42(2):169-75.

PMID:
14752882
18.

Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosis.

Krams M, Parwaresch R, Sipos B, Heidorn K, Harms D, Rudolph P.

Oncogene. 2004 Jan 15;23(2):588-95.

PMID:
14724587
19.

Group II rhabdomyosarcoma and rhabdomyosarcomalike tumors: is radiotherapy necessary?

Schuck A, Mattke AC, Schmidt B, Kunz DS, Harms D, Knietig R, Treuner J, Koscielniak E.

J Clin Oncol. 2004 Jan 1;22(1):143-9.

PMID:
14701776
20.

Partial nephrectomy for unilateral Wilms tumor: results of study SIOP 93-01/GPOH.

Haecker FM, von Schweinitz D, Harms D, Buerger D, Graf N.

J Urol. 2003 Sep;170(3):939-42; discussion 943-4.

PMID:
12913746

Supplemental Content

Loading ...
Support Center